Refractory Hypotension During ECMO: Words of Caution When Using Methylene Blue

J Cardiothorac Vasc Anesth. 2022 Feb;36(2):631-632. doi: 10.1053/j.jvca.2021.08.032. Epub 2021 Aug 27.

Authors

Patrick M Wieruszewski¹, Christoph G Nabzdyk², Heather Bowman³, Troy G Seelhammer²

Affiliations

¹ Department of Pharmacy, Mayo Clinic, Rochester, MN; Department of Anesthesiology, Mayo Clinic, Rochester, MN. Electronic address: wieruszewski.patrick@mayo.edu.
² Department of Anesthesiology, Mayo Clinic, Rochester, MN.
³ Department of Mechanical Engineering, Zhao Laboratory, Massachusetts Institute of Technology, Cambridge, MA.

PMID: 34518102
DOI: 10.1053/j.jvca.2021.08.032

No abstract available

Publication types

Letter
Comment

MeSH terms

Extracorporeal Membrane Oxygenation* / adverse effects
Humans
Hypotension* / chemically induced
Methylene Blue / adverse effects
Vasoconstrictor Agents / therapeutic use

Substances

Vasoconstrictor Agents
Methylene Blue